Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease.

Kalligeros, Markos; Tsochatzis, Emmanuel A

Kalligeros, Markos; Tsochatzis, Emmanuel A.

Afiliação

Kalligeros M; Division of Internal Medicine, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, USA.
Tsochatzis EA; UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.

Hepatobiliary Surg Nutr ; 13(2): 311-313, 2024 Apr 03.

Article em En | MEDLINE | ID: mdl-38617476

Palavras-chave

Fibroscan; cirrhosis; enhanced liver fibrosis (ELF); fibrosis-4 (FIB-4); metabolic-dysfunction associated steatotic liver disease (MASLD)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hepatobiliary Surg Nutr Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google